Sarsia Seed invests in early-stage science and technology based companies operating in the areas of Energy / Technology and Biotechnology / Life Sciences. A typical first round of investment will be in the area of 2-5 million NOK for a 10% to 40% ownership stake. The fund always allocate capital for follow on investments as the company matures. Sarsia Seed is keen to attract co-investments from professional and/or corporate investors as early as possible so as to carry prospects forward at the fastest possible pace.
Investment sectors
Early-stage start-up companies look for more than just financial support from their investors. Thus, we aim to add value to our investments by contributing our expertise towards the companies’ technological and/or commercial development. Sarsia Seed is primarily looking for companies with an attachment to Norway but may also invest in European based companies if the fit is good.
Biotechnology/Life Sciences
- Biomedicine and Biotechnology
- Medical instrumentation and technology platforms
- Medical diagnostics and other biotechnology products
- Marine and aquaculture technology
Energy/Technology
-
Sensors, Analytics, Industrial IoT
-
Material technology, solar, battery, sustainable production technologies
-
Electric power analytics, control and monitoring technologies
-
Technologies for energy production, efficient use and distribution
-
Advanced analytics, machine learning, AI, hardware and Software service models.